Terms: = Leukemia AND COX6C, P09669, 1345, ENSG00000164919 AND Treatment
4 results:
1. The clinical and pathological features of plasma cell myeloma post solid organ transplantation.
Ofori K; Soderquist CR; Murty VV; Park D; Vlad G; Leeman-Neill RJ; Lentzsch S; Alobeid B; Bhagat G
Am J Hematol; 2020 Dec; 95(12):1531-1541. PubMed ID: 32864761
[TBL] [Abstract] [Full Text] [Related]
2. Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada.
Lee LJ; Toze CL; Huang SJT; Gillan TL; Connors JM; Sehn LH; Bruyere H; Leitch H; Ramadan KM; Gerrie AS
Leuk Lymphoma; 2018 Jun; 59(6):1356-1363. PubMed ID: 29032719
[TBL] [Abstract] [Full Text] [Related]
3. ATRA and anthracycline-based chemotherapy in the treatment of childhood acute promyelocytic leukemia (APL): A 10-year experience in Tunisia.
Jeddi R; Ghédira H; Ben Abdennebi Y; Kacem K; Ben Amor R; Aissaoui L; Bouterâa W; Ben Lakhal R; Ben Abid H; Menif S; Belhadjali Z; Meddeb B
Med Oncol; 2011 Dec; 28(4):1618-23. PubMed ID: 20697840
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of the cellularity and presence of residual leukemia in bone marrow aspirate and biopsy specimens in pediatric patients with acute lymphoblastic leukemia (ALL) at day 7-14 of chemotherapy.
Kidd PG; Saminathan T; Drachtman RA; Ettinger LJ
Med Pediatr Oncol; 1997 Dec; 29(6):541-3. PubMed ID: 9324341
[TBL] [Abstract] [Full Text] [Related]
